Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients. 2023

Miloš Marković, and Nataša Petronijević, and Milena Stašević, and Ivana Stašević Karličić, and Milica Velimirović, and Tihomir Stojković, and Slavica Ristić, and Mina Stojković, and Nataša Milić, and Tatjana Nikolić
Clinic for Mental Disorders "Dr Laza Lazarević", 11000 Belgrade, Serbia.

Tryptophan (TRP) catabolites exert neuroactive effects, with the plethora of evidence suggesting that kynurenic acid (KYNA), a catabolite of the kynurenine pathway (KP), acts as the regulator of glutamate and acetylcholine in the brain, contributing to the schizophrenia pathophysiology. Newer evidence regarding measures of KP metabolites in the blood of schizophrenia patients and from the central nervous system suggest that blood levels of these metabolites by no means could reflect pathological changes of TRP degradation in the brain. The aim of this study was to investigate plasma concentrations of TRP, kynurenine (KYN) and KYNA at the acute phase and remission of schizophrenia in a prospective, case-control study of highly selected and matched schizophrenia patients and healthy individuals. Our study revealed significantly decreased KYN and KYNA in schizophrenia patients (p < 0.001), irrespective of illness state, type of antipsychotic treatment, number of episodes or illness duration and no differences in the KYN/TRP ratio between schizophrenia patients and healthy individuals. These findings could be interpreted as indices that kynurenine pathway might not be dysregulated in the periphery and that other factors contribute to observed disturbances in concentrations, but as our study had certain limitations, we cannot draw definite conclusions. Further studies, especially those exploring other body compartments that participate in kynurenine pathway, are needed.

UI MeSH Term Description Entries
D007736 Kynurenic Acid A broad-spectrum excitatory amino acid antagonist used as a research tool. Kynurenate,Acid, Kynurenic
D007737 Kynurenine A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D014364 Tryptophan An essential amino acid that is necessary for normal growth in infants and for NITROGEN balance in adults. It is a precursor of INDOLE ALKALOIDS in plants. It is a precursor of SEROTONIN (hence its use as an antidepressant and sleep aid). It can be a precursor to NIACIN, albeit inefficiently, in mammals. Ardeydorm,Ardeytropin,L-Tryptophan,L-Tryptophan-ratiopharm,Levotryptophan,Lyphan,Naturruhe,Optimax,PMS-Tryptophan,Trofan,Tryptacin,Tryptan,Tryptophan Metabolism Alterations,ratio-Tryptophan,L Tryptophan,L Tryptophan ratiopharm,PMS Tryptophan,ratio Tryptophan
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control

Related Publications

Miloš Marković, and Nataša Petronijević, and Milena Stašević, and Ivana Stašević Karličić, and Milica Velimirović, and Tihomir Stojković, and Slavica Ristić, and Mina Stojković, and Nataša Milić, and Tatjana Nikolić
January 2010, Archives of general psychiatry,
Miloš Marković, and Nataša Petronijević, and Milena Stašević, and Ivana Stašević Karličić, and Milica Velimirović, and Tihomir Stojković, and Slavica Ristić, and Mina Stojković, and Nataša Milić, and Tatjana Nikolić
June 2010, Schizophrenia research,
Miloš Marković, and Nataša Petronijević, and Milena Stašević, and Ivana Stašević Karličić, and Milica Velimirović, and Tihomir Stojković, and Slavica Ristić, and Mina Stojković, and Nataša Milić, and Tatjana Nikolić
September 2006, Schizophrenia research,
Miloš Marković, and Nataša Petronijević, and Milena Stašević, and Ivana Stašević Karličić, and Milica Velimirović, and Tihomir Stojković, and Slavica Ristić, and Mina Stojković, and Nataša Milić, and Tatjana Nikolić
April 2006, Psychological medicine,
Miloš Marković, and Nataša Petronijević, and Milena Stašević, and Ivana Stašević Karličić, and Milica Velimirović, and Tihomir Stojković, and Slavica Ristić, and Mina Stojković, and Nataša Milić, and Tatjana Nikolić
July 2018, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
Miloš Marković, and Nataša Petronijević, and Milena Stašević, and Ivana Stašević Karličić, and Milica Velimirović, and Tihomir Stojković, and Slavica Ristić, and Mina Stojković, and Nataša Milić, and Tatjana Nikolić
June 2023, Cerebral cortex (New York, N.Y. : 1991),
Miloš Marković, and Nataša Petronijević, and Milena Stašević, and Ivana Stašević Karličić, and Milica Velimirović, and Tihomir Stojković, and Slavica Ristić, and Mina Stojković, and Nataša Milić, and Tatjana Nikolić
April 2013, Journal of clinical psychopharmacology,
Miloš Marković, and Nataša Petronijević, and Milena Stašević, and Ivana Stašević Karličić, and Milica Velimirović, and Tihomir Stojković, and Slavica Ristić, and Mina Stojković, and Nataša Milić, and Tatjana Nikolić
March 2010, Journal of psychiatry & neuroscience : JPN,
Miloš Marković, and Nataša Petronijević, and Milena Stašević, and Ivana Stašević Karličić, and Milica Velimirović, and Tihomir Stojković, and Slavica Ristić, and Mina Stojković, and Nataša Milić, and Tatjana Nikolić
September 2007, Schizophrenia research,
Miloš Marković, and Nataša Petronijević, and Milena Stašević, and Ivana Stašević Karličić, and Milica Velimirović, and Tihomir Stojković, and Slavica Ristić, and Mina Stojković, and Nataša Milić, and Tatjana Nikolić
March 2013, Schizophrenia research,
Copied contents to your clipboard!